STOCK TITAN

Voyager Therapeutics (VYGR) Form 144: 3,301-share proposed sale; insider sold 3,525

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Voyager Therapeutics submitted a Form 144 notice disclosing a proposed sale of 3,301 common shares. The filing identifies the shares as Restricted Stock Vesting tied to compensation with a vesting date of 02/17/2026. The filing also records a prior sale by Todd Carter of 3,525 common shares on 02/10/2026. The Form lists 02/18/2026 and notes the securities trade on NASDAQ.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 shows proposed resale following restricted stock vesting and a recent insider sale.

The filing lists a proposed sale of 3,301 shares of common stock described as Restricted Stock Vesting with a vesting date of 02/17/2026, and a prior sale of 3,525 shares on 02/10/2026.

Such notices typically document planned dispositions under resale rules; the actual timing and execution depend on holder decisions and market arrangements. Subsequent filings or broker reports would show completed transactions and proceeds if executed.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the VYGR Form 144 disclose?

The Form 144 discloses a proposed sale of 3,301 common shares tied to restricted stock vesting on 02/17/2026. It also records a prior sale of 3,525 shares by Todd Carter on 02/10/2026, and lists NASDAQ.

Who is the reported seller in the VYGR filing?

The filing identifies Todd Carter as the person associated with the prior sale of 3,525 shares on 02/10/2026. The proposed sale of 3,301 shares is linked to restricted stock vesting and compensation dated 02/17/2026.

What type of shares are being offered in the VYGR Form 144?

The shares to be sold are described as Restricted Stock Vesting issued as compensation with a vesting date of 02/17/2026. The filing lists the quantity as 3,301 common shares to be offered.

When were the prior reported sales for VYGR executed?

The previously reported sale in the excerpt shows 3,525 common shares sold on 02/10/2026 by Todd Carter. This sale is listed under 'Securities Sold During The Past 3 Months' in the filing.

Does the Form 144 show where VYGR securities trade?

Yes; the filing entry includes NASDAQ as the market where the common securities trade. The Form lists the filing date as 02/18/2026 alongside the exchange designation.
Voyager Therapeutics Inc

NASDAQ:VYGR

VYGR Rankings

VYGR Latest News

VYGR Latest SEC Filings

VYGR Stock Data

190.15M
46.30M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
LEXINGTON